There is evidence for synergistic effects of BET protein and HDAC inhibitors in transcription regulation [98] and tumor therapy [99,100], but in NPCD patient-derived fibroblasts, JQ1 did not significantly enhance the SAHA-induced reduction in cholesterol accumulation. The gene discussed is HDAC9; the disease is neoplasm.